GlassScriptPhysician profile
Michael Edward Mcandrew
NPI 1730180530
$13,033.57
in general payments reported to CMS, 2019-2025
22 companies · $8,026 in 2025
The $8,026 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,462 · 2021: $118 · 2022: $80.81 · 2023: $1,743 · 2024: $1,604 · 2025: $8,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,194 · Education: $4,109 · Food and Beverage: $2,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,193.63 |
| Education | $4,109.27 |
| Food and Beverage | $2,070.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,223.01 | 2023-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $3,739.86 | 2019-2025 | Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement, Gore Viabahn Vbx Balloon Expandable Endo |
| Organogenesis INC. | $279.49 | 2021-2024 | Puraply, Affinity |
| Braintree Laboratories, INC. | $153.78 | 2019-2025 | Sutab, Suflave |
| Ethicon US, LLC | $141.32 | 2019-2025 | Stratafix, Enseal |
| Smith+Nephew, INC. | $76.44 | 2021-2025 | Stravix, Collagenase Santyl |
| Conmed Corporation | $67.15 | 2025 | Airseal, Conmed Specimen Retrieval |
| Medtronic, INC. | $64.86 | 2021-2023 | Venaseal |
| Abbvie INC. | $32.80 | 2021-2024 | |
| Davol INC. | $30.77 | 2024 | Phasix Mesh |
| Depuy Synthes Sales INC. | $28.54 | 2019 | |
| Merck Sharp & Dohme LLC | $28.22 | 2025 | Bridion |
| Takeda Pharmaceuticals U.S.A., INC. | $23.54 | 2022 | |
| Biotissue Holdings INC. | $19.35 | 2024 | |
| Aroa Biosurgery Incorporated | $18.04 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $17.98 | 2022 | |
| Ascensia Diabetes Care US INC. | $17.66 | 2025 | |
| Heartflow, INC. | $16.75 | 2024 | |
| Solventum Corporation | $16.60 | 2024 | Prevena, V.A.C.Instill |
| Tactile Systems Technology INC | $12.91 | 2019 | |
| Bioventus LLC | $12.63 | 2022 | |
| Molnlycke Health Care US, LLC | $11.87 | 2024 | Mepilex Border Flex, Mextra Superabsorbant, Exufiber Ag+ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcandrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.